Compare McKesson Corporation (MCK) vs Twilio Inc (TWLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Twilio Inc — how do they compare? McKesson Corporation trades at $828.8 (market cap $97.35B), while Twilio Inc trades at $200.22 (market cap $31.15B). The key difference: McKesson Corporation is far larger — about 3.1× Twilio Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Twilio Inc pays none. Which is the better fit depends on your goals.
| MCK | TWLO | |
|---|---|---|
Market Cap | $97.35B | $31.15B |
Sector | Health | Technology |
52-Week High | $995.69 | $236.64 |
52-Week Low | $659.01 | $92.44 |
Enterprise Value | $101.98B | $29.87B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Twilio (TWLO) trades at $208.56, up 0.86% with a bullish technical outlook. The stock has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 6, 2026. Revenue grew to $5.07B in 2025, and net income turned positive at $33.83M. Analyst sentiment is strongly positive with a consensus price target of $223.00. Operating cash flow improved significantly to $1.00B in 2025, indicating strengthening financial health.
The outlook for Twilio is optimistic due to consistent earnings beats and robust revenue growth, though high valuation multiples pose risks. Key opportunities include AI-driven communication tools and margin expansion under new leadership. Risks include intense competition and execution challenges in sustaining profitability. Investors should monitor Q2 2026 earnings for continued momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Twilio Inc
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →
